Craft
Ribon Therapeutics

Ribon Therapeutics

Total Funding

$65 M

Ribon Therapeutics Summary

Company summary

Overview
Ribon Therapeutics is pioneering the discovery and development of monoPARP (mono ADP-ribose polymerase) inhibitors to block cancer cells’ fundamental ability to survive under stress
Type
Private
Status
Active
Founded
2015
HQ
Cambridge, MA, US | view all locations
Website
http://www.ribontx.com/
Cybersecurity rating
Sectors

Key people

  • James Audia, Executive Director, Chicago Biomedical Consortium

    • Ribon Therapeutics, Executive Director, Chicago Biomedical Consortium

      • Jodie Morrison

        Jodie Morrison, Chair of The Board Of Directors

        • Laura Brass, Managing Director, Novartis Venture Fund

          LocationsView all

          1 location detected

          • Cambridge, MA HQ

            United States

            35 Cambridgepark Dr

          Footer menu